CareDx Inc [NASDAQ: CDNA] jumped around 3.49 points on Thursday, while shares priced at $41.43 at the close of the session, up 9.20%.
CareDx Inc stock is now 92.07% up from its year-to-date (YTD) trading value. CDNA Stock saw the intraday high of $42.79 and lowest of $38.59 per share. The companyâ€™s 52-week high price is 38.67, which means current price is +217.71% above from all time high which was touched on 10/01/20.
Compared to the average trading volume of 486.47K shares, CDNA reached a trading volume of 1822960 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about CareDx Inc [CDNA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CDNA shares is $44.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CDNA stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for CareDx Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 05, 2020. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on June 26, 2020, representing the official price target for CareDx Inc stock. Previously, the target price had yet another drop from $40 to $37, while H.C. Wainwright kept a Buy rating on CDNA stock.
The Average True Range (ATR) for CareDx Inc is set at 2.01, with the Price to Sales ratio for CDNA stock in the period of the last 12 months amounting to 12.76. The Price to Book ratio for the last quarter was 7.11, with the Price to Cash per share for the same quarter was set at 4.58. Price to Free Cash Flow for CDNA in the course of the last twelve months was 123.33 with Quick ratio for the last quarter at 4.30.
How has CDNA stock performed recently?
CareDx Inc [CDNA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 34.16. With this latest performance, CDNA shares gained by 22.61% in over the last four-week period, additionally plugging by 100.73% over the last 6 months â€“ not to mention a rise of 74.81% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CDNA stock in for the last two-week period is set at 73.47, with the RSI for the last a single of trading hit 80.22, and the three-weeks RSI is set at 68.93 for CareDx Inc [CDNA]. The present Moving Average for the last 50 days of trading for this stock 33.60, while it was recorded at 36.73 for the last single week of trading, and 28.03 for the last 200 days.
CareDx Inc [CDNA]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and CareDx Inc [CDNA] shares currently have an operating margin of -18.83 and a Gross Margin at +63.20. CareDx Incâ€™s Net Margin is presently recorded at -17.29.
Return on Total Capital for CDNA is now -24.10, given the latest momentum, and Return on Invested Capital for the company is -22.50. Return on Equity for this stock declined to -22.54, with Return on Assets sitting at -15.02. When it comes to the capital structure of this company, CareDx Inc [CDNA] has a Total Debt to Total Equity ratio set at 3.33. Additionally, CDNA Total Debt to Total Capital is recorded at 3.22, with Total Debt to Total Assets ending up at 2.08. Long-Term Debt to Equity for the company is recorded at 0.07, with the Long-Term Debt to Total Capital now at 0.07.
Reflecting on the efficiency of the workforce at the company, CareDx Inc [CDNA] managed to generate an average of -$56,912 per employee. Receivables Turnover for the company is 7.52 with a Total Asset Turnover recorded at a value of 0.87.CareDx Incâ€™s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.30 and a Current Ratio set at 4.40.
Earnings analysis for CareDx Inc [CDNA]
With the latest financial reports released by the company, CareDx Inc posted 0.02/share EPS, while the average EPS was predicted by analysts to be reported at 0.01/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 100.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CDNA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CareDx Inc go to 20.00%.
Insider trade positions for CareDx Inc [CDNA]
There are presently around $2,045 million, or 97.01% of CDNA stock, in the hands of institutional investors. The top three institutional holders of CDNA stocks are: FRED ALGER MANAGEMENT, LLC with ownership of 5,085,937, which is approximately -50.384% of the companyâ€™s market cap and around 2.30% of the total institutional ownership; BLACKROCK INC., holding 3,278,235 shares of the stock with an approximate value of $135.82 million in CDNA stocks shares; and INVESCO LTD., currently with $126.74 million in CDNA stock with ownership of nearly 10.821% of the companyâ€™s market capitalization.
Positions in CareDx Inc stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 116 institutional holders increased their position in CareDx Inc [NASDAQ:CDNA] by around 8,540,218 shares. Additionally, 72 investors decreased positions by around 8,754,269 shares, while 17 investors held positions by with 32,057,546 shares. The mentioned changes placed institutional holdings at 49,352,033 shares, according to the latest SEC report filing. CDNA stock had 60 new institutional investments in for a total of 3,014,653 shares, while 12 institutional investors sold positions of 204,370 shares during the same period.